Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Van Ness

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Cancer Research|August 15, 1995
Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6D Billadeau, D F Jelinek, N Shah, et al.
Cancer Research|June 1, 1997
Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6D Billadeau, P Liu, D Jelinek, et al.
Leukemia|July 1, 1992
B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factorsS L Zaknoen, S L Christian, R Suen, et al.
British Journal of Haematology|October 1, 1992
Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlationsE Paietta, B Van Ness, J Bennett, et al.
Cancer Genetics and Cytogenetics|May 1, 1992
Translocation (2;9)(p12;p23) in a case of acute leukemia with t(4;11)(q21;q23). Lack of rearrangement of the kappa and interferon gene lociE Paietta, B Van Ness, M M Le Beau, et al.
Leukemia & Lymphoma|January 1, 1995
Sequential phenotyping of myeloma patients on chemotherapy: persistence of activated T-cells and natural killer cellsN E Kay, M M Oken, R Kyle, et al.
Blood|December 1, 1991
Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual diseaseD Billadeau, M Blackstadt, P Greipp, et al.
Leukemia & Lymphoma|April 8, 1999
Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487)N Kay, T Leong, R A Kyle, et al.
Nucleic Acids Research|February 11, 1988
Inducible DNA-protein interactions of the murine kappa immunoglobulin enhancer in intact cells: comparison with in vitro interactionsR Hromas, U Pauli, A Marcuzzi, et al.
Leukemia Research|January 1, 1991
Unexpected immunoglobulin light chain gene rearrangements in myeloid antigen positive acute lymphoid leukemiaE Paietta, B Van Ness, J M Bennett, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Cancer Research|August 15, 1995
Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6D Billadeau, D F Jelinek, N Shah, et al.
Cancer Research|June 1, 1997
Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6D Billadeau, P Liu, D Jelinek, et al.
Leukemia|July 1, 1992
B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factorsS L Zaknoen, S L Christian, R Suen, et al.
British Journal of Haematology|October 1, 1992
Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlationsE Paietta, B Van Ness, J Bennett, et al.
Cancer Genetics and Cytogenetics|May 1, 1992
Translocation (2;9)(p12;p23) in a case of acute leukemia with t(4;11)(q21;q23). Lack of rearrangement of the kappa and interferon gene lociE Paietta, B Van Ness, M M Le Beau, et al.
Leukemia & Lymphoma|January 1, 1995
Sequential phenotyping of myeloma patients on chemotherapy: persistence of activated T-cells and natural killer cellsN E Kay, M M Oken, R Kyle, et al.
Blood|December 1, 1991
Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual diseaseD Billadeau, M Blackstadt, P Greipp, et al.
Leukemia & Lymphoma|April 8, 1999
Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487)N Kay, T Leong, R A Kyle, et al.
Nucleic Acids Research|February 11, 1988
Inducible DNA-protein interactions of the murine kappa immunoglobulin enhancer in intact cells: comparison with in vitro interactionsR Hromas, U Pauli, A Marcuzzi, et al.
Leukemia Research|January 1, 1991
Unexpected immunoglobulin light chain gene rearrangements in myeloid antigen positive acute lymphoid leukemiaE Paietta, B Van Ness, J M Bennett, et al.
Pageof 7